Geneos Wealth Management’s Nuveen Churchill Direct Lending NCDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-522
Closed -$8.45K 2937
2025
Q2
$8.45K Buy
522
+18
+4% +$285 ﹤0.01% 2386
2025
Q1
$8.56K Buy
+504
New +$8.66K ﹤0.01% 2611

Other funds holding NCDL

Geneos Wealth Management's NCDL Position: Q3 2025 in Review

Geneos Wealth Management sold out of Nuveen Churchill Direct Lending (NCDL) in Q3 2025, closing a stake of 522 shares — an estimated $8.45K sold.

Geneos Wealth Management first reported a position in NCDL in Q1 2025 and held it in 2 quarters. The position peaked at $8.56K in Q1 2025. 78 funds tracked by Wall St. Rank hold NCDL as of Q3 2025.

  • Geneos Wealth Management reported no remaining Nuveen Churchill Direct Lending position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 522 Nuveen Churchill Direct Lending shares in Q3 2025, an estimated $8.45K.
  • Geneos Wealth Management first reported a position in Nuveen Churchill Direct Lending in Q1 2025 and held it in 2 quarters.
  • Geneos Wealth Management's Nuveen Churchill Direct Lending position peaked at $8.56K in Q1 2025.
  • 78 funds tracked by Wall St. Rank held Nuveen Churchill Direct Lending as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.